Related Experiment Video
Updated: Jan 15, 2026

07:57
Integrated Compensatory Responses in a Human Model of Hemorrhage
Published on: November 20, 2016
13.0K
Key Indicators Associated With Survival in Pediatric Trauma Massive Transfusion Protocol
Theodore Wang1, Sorasicha Nithikasem1, Thomas Hong1
1Division of Pediatric Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.
The Journal of Surgical Research
|October 7, 2025
Summary
This study identified factors influencing survival in pediatric trauma patients receiving massive transfusion protocols (MTP). Tachycardia and Level I trauma centers were protective, while hypothermia and severe injury indicated poor outcomes.
Area of Science:
- Trauma Surgery
- Pediatric Critical Care
- Transfusion Medicine
Background:
- No established massive transfusion protocol (MTP) scoring system exists for pediatric trauma patients.
- This study evaluated factors associated with survival in pediatric trauma patients undergoing MTP.
Purpose of the Study:
- To identify predictors of survival in pediatric trauma patients requiring MTP.
- To inform the development of optimized MTP strategies for children.
Main Methods:
- Retrospective analysis of the National Trauma Data Bank (2017-2019) for pediatric patients (<18 years) receiving MTP (>40 mL/kg blood products within 4h).
- Exclusion of patients with non-survivable injuries or no signs of life on admission.
- Multivariable regression analysis to determine factors predictive of survival.
Main Results:
- Of 947 pediatric patients requiring MTP, 68% survived.
- Survival was associated with hemorrhage control surgery, tachycardia, and Level I trauma center presentation.
- Poor prognostic factors included hypothermia, severe Glasgow Coma Score (GCS), high Injury Severity Score (ISS), self-payment, and >80 mL/kg transfused blood products.
Conclusions:
- Tachycardia and Level I pediatric trauma centers are protective factors in MTP.
- Hypothermia, severe GCS, severe ISS, self-payment, and excessive blood product transfusion (>80 mL/kg) are associated with decreased survival.
- Development of predictive tools is crucial to guide MTP use and identify patients needing alternative interventions.

